NCT02706626 2023-01-26Trial of Brigatinib After Treatment With Next-Generation ALK InhibitorsCriterium, Inc.Phase 2 Terminated32 enrolled 9 charts
NCT04634110 2022-10-24Brigatinib Before Brain Irradiation Trial (B3i Trial)University of Colorado, DenverPhase 2 Terminated1 enrolled 6 charts